Invest in 3 Healthcare Mutual Funds as Inflation Eases

Written by Emily J. Thompson, Senior Investment Analyst

Source: NASDAQ.COM

Updated: Dec 19 2025

0mins

Source: NASDAQ.COM

Inflation and Labor Market Trends: Recent data shows a decrease in inflation rates, with the year-over-year Consumer Price Index (CPI) rising 2.7% in November 2025, supporting a positive outlook for the healthcare sector, which benefits from stable demand during economic instability.
Healthcare Mutual Fund Recommendations: Three healthcare mutual funds—Fidelity Select Biotechnology Portfolio (FBIOX), Franklin Biotechnology Discovery Fund (FBDIX), and PGIM Jennison Health Sciences (PHLAX)—are recommended for long-term investment due to their strong performance, low expense ratios, and favorable Zacks Mutual Fund Rankings.
Fund Performance Details: FBIOX has 3-year and 5-year returns of 16.9% and 4.7%, respectively, while FBDIX shows 22.4% and 7.3%, and PHLAX has 14.3% and 8.9%. Each fund is managed by experienced professionals and focuses on biotechnology and health sciences.
Investment Insights: Zacks Investment Research offers insights into top-performing mutual funds and stocks, highlighting the potential for significant returns, with a particular emphasis on one stock that could outperform previous recommendations.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.